BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 897648)

  • 1. [Treatment of heart failure with phentolamine (Regitin)].
    Imhof P
    Schweiz Med Wochenschr; 1977 Jul; 107(29):1041-3. PubMed ID: 897648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilators in left ventricular failure.
    Camerini F; Mestroni L; Neri R; Humar F
    G Ital Cardiol; 1984 Sep; 14(9):685-93. PubMed ID: 6510623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)].
    Solignac A
    Nouv Presse Med; 1978 Mar; 7(12):1013-20. PubMed ID: 96422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of vasodilators in the treatment of congestive heart failure and myocardial ischaemia (author's transl)].
    Tarnow J
    Anaesthesist; 1981 Jun; 30(6):269-79. PubMed ID: 6791517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute and chronic cardiac decompensation: is vasodilator therapy useful?].
    Malacco E; Limonta A; Milanesi A; Micossi P
    Minerva Med; 1982 Jan; 73(1-2):25-32. PubMed ID: 7058000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
    Francoual M
    Nouv Presse Med; 1979 Jan; 8(4):293-6. PubMed ID: 122024
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of acute and chronic congestive heart failure by vasodilator-afterload reduction.
    Mason DT; Awan NA; Joye JA; Lee G; DeMaria AN; Amsterdam EA
    Arch Intern Med; 1980 Dec; 140(12):1577-81. PubMed ID: 6257193
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG; Nikitin N; McGowan J
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of heart failure: status of therapy with vasodilator agents].
    Just H
    Herz; 1987 Dec; 12 Suppl 1():22-6. PubMed ID: 3436615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamic effects of vasodilators in aged patients with heart failure].
    Chen RX; Lu QQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Sep; 13(4):249-51, 317. PubMed ID: 3836878
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM; Lee FA
    Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Basic Res Cardiol; 1991; 86 Suppl 1():107-12. PubMed ID: 1827977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasodilators: treatment of cardiac insufficiency].
    Francoual M; Lellouche D; Castaigne A; Estampes B; Vernant P
    Rev Prat; 1977 Oct; 27(47):3169-79. PubMed ID: 414346
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
    J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances].
    Thormann J; Kramer W; Dieterich HA
    Herz; 1990 Jun; 15(3):190-201. PubMed ID: 2198220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.